Bacillus calmette-guerin substrain tice live antigen Active Not Recruiting Phase 1 Trials for Stage 0is Bladder Urothelial Carcinoma / Stage I Bladder Cancer / Stage 0a Bladder Urothelial Carcinoma / Recurrent Bladder Carcinoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02808143Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer